After a new international call for tender lasting several months, the Wedia solution has been selected by one of the world’s leading pharmaceutical and agrochemical groups.
“With this new success, Wedia is now a partner of 4 of the 10 largest German companies. Moreover, this project confirms Wedia’s expertise in the pharmaceutical field, where regulatory constraints are imposed on marketing and sales teams and the content they have to manage,” explains Nicolas Boutet, CEO of Wedia.
For this client, there are many objectives: sharing content between all of its entities, integrating the solution seamlessly with its application ecosystem (CMS, PIM, etc.) and, above all, delivering marketing content that is contextualized to the country, audience and the devices used across all websites, brand sites and social networks.
“I am very proud of our teams in charge of the German market who won this tender against some major American and German Digital Asset Management players. Wedia was chosen for its advanced artificial intelligence functionalities, its range and richness in personalization capabilities to best respond and adapt to the customer’s context, and most importantly, its open and interconnectable solution, notably with the CMS, that’s able to dynamically deliver marketing content on a large scale and in a personalized manner across all digital channels of this global company.” Nicolas BOUTET adds.